| Product Name | MF | CAS | Details |
|---|
| Anti-TNFRSF7 / CD27 Reference Antibody (Organon patent anti-CD27) | Details |
| Anti-TNFRSF7 / CD27 Reference Antibody (varlilumab) | Details |
| Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab) | Details |
| Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (urelumab) | Details |
| Anti-TNFRSF9 / 4-1BB / CD137 Reference Antibody (utomilumab) | Details |
| Anti-TNFSF1 / TNFb Reference Antibody (pateclizumab) | Details |
| Anti-TNFSF11 / RANKL / CD254 Reference Antibody (denosumab) | Details |
| Anti-TNFSF12 / TWEAK Reference Antibody (RO5458640) | Details |
| Anti-TNFSF13 / APRIL / CD256 Reference Antibody (BION-1301) | Details |
| Anti-TNFSF13 / APRIL / CD256 Reference Antibody (sibeprenlimab) | Details |
| Anti-TNFSF13B / BAFF / CD257 Reference Antibody (belimumab) | Details |
| Anti-TNFSF13B / BAFF / CD257 Reference Antibody (tabalumab) | Details |
| Anti-TNFSF14 / LIGHT / CD258 Reference Antibody (SAR252067) | Details |
| Anti-TNFSF2 / TNFa Reference Antibody (adalimumab) | Details |
| Anti-TNFSF2 / TNFa Reference Antibody (CDP571) | Details |
| Anti-TNFSF2 / TNFa Reference Antibody (certolizumAb) | Details |
| Anti-TNFSF2 / TNFa Reference Antibody (CMAB008) | Details |
| Anti-TNFSF2 / TNFa Reference Antibody (Epitomics patent anti-TNFα) | Details |
| Anti-TNFSF2 / TNFa Reference Antibody (ESBA 105) | Details |
| Anti-TNFSF2 / TNFa Reference Antibody (golimumab) | Details |
| Anti-TNFSF2 / TNFa Reference Antibody (hMAK195) | Details |
| Anti-TNFSF2 / TNFa Reference Antibody (infliximab) | Details |
| Anti-TNFSF4 / OX40L / CD252 Reference Antibody (amlitelimab) | Details |
| Anti-TNFSF4 / OX40L / CD252 Reference Antibody (oxelumab) | Details |
| Anti-TNFSF5 / CD40L / CD154 Reference Antibody (dapirolizumab) | Details |
| Anti-TNFSF5 / CD40L / CD154 Reference Antibody (ruplizumab) | Details |
| Anti-TNFSF7 / CD27L / CD70 Reference Antibody (cusatuzumab) | Details |
| Anti-TNFSF7 / CD27L / CD70 Reference Antibody (vorsetuzumab) | Details |
| Anti-TNFSF9 / 4-1BBL Reference Antibody (Abbvie patent anti-TNFSF9) | Details |
| Anti-TPBG Reference Antibody (naptumomAb) | Details |
| Anti-TPBG Reference Antibody (PF-06263507) | Details |
| Anti-TPBG Reference Antibody (Wyeth patent anti-5T4) | Details |
| Anti-TPSAB1 Reference Antibody (Genentech patent anti-Tryptase Beta 1) | Details |
| Anti-TREM1 / CD354 Reference Antibody (PY159) | Details |
| Anti-TrkA / NTRK1 Reference Antibody (GBR 900) | Details |
| Anti-TrkB / NTRK2 Reference Antibody (Rinat patent anti-TrkB) | Details |
| Anti-TROP2 Reference Antibody (sacituzumab) | Details |
| Anti-TRP1 / TYRP1 Reference Antibody (flanvotumab) | Details |
| Anti-TSHR Reference Antibody (K1-70) | Details |
| Anti-TSLP Reference Antibody (Schering patent anti-TSLP) | Details |
| Anti-TSLP Reference Antibody (tezepelumab) | Details |
| Anti-TSPAN26 / CD37 Reference Antibody (AGS67E) | Details |
| Anti-TSPAN26 / CD37 Reference Antibody (lilotomab) | Details |
| Anti-TSPAN26 / CD37 Reference Antibody (naratuximab) | Details |
| Anti-TSPAN26 / CD37 Reference Antibody (otlertuzumab) | Details |
| Anti-TSPAN8 Reference Antibody (INSERM patent anti-CO-029) | Details |
| Anti-TYRO3 Reference Antibody (ELB031) | Details |
| Anti-VCAM1 / CD106 Reference Antibody (Hanwha patent anti-VCAM-1) | Details |
| Anti-VEGF Reference Antibody (BioMab patent anti-VEGF) | Details |
| Anti-VEGF Reference Antibody (Domantis patent anti-VEGF) | Details |
| Anti-VEGFA Reference Antibody (bevacizumab) | Details |
| Anti-VEGFA Reference Antibody (ranibizumab) | Details |
| Anti-VEGFA Reference Antibody (varisacumab) | Details |
| Anti-VEGFB Reference Antibody (CSL346) | Details |
| Anti-VEGFC Reference Antibody (VGX100) | Details |
| Anti-VEGFR1 / FLT1 Reference Antibody (Abbott patent anti-Flt1) | Details |
| Anti-VEGFR1 / FLT1 Reference Antibody (icrucumab) | Details |
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (alacizumAb) | Details |
| Tween 20 | C26H50O10 | 9005-64-5 | Details |
| HEPES Buffer(1M,pH7.3) | Details |
| Protease Inhibitor Cocktail for plant cell and tissue extracts(100×) | Details |
| cis-9-Hexadecenoic Acid | C16H30O2 | 373-49-9 | Details |
| 0.2% Gelatin Solution | Details |
| Cedar oil | NULL | 8000-27-9 | Details |
| 6α-Hydroxy paclitaxel | C47H51NO15 | 153212-75-0 | Details |
| pH 7.0 Dilution Buffer | Details |
| Thidiazuron | C9H8N4OS | 51707-55-2 | Details |
| RPMI 1640 Medium(Glucose, Bicarbonate Sodium,w/o L-Glutamine,w/o HEPES,Phenol Red,w/o Sodium pyruvate) | Details |
| Salmonella Shigella Agar | Details |
| Columbia Blood Agar Base | Details |
| MacConkey Agar | Details |
| Anti-VEGFR3 / FLT4 Reference Antibody (LY3022856) | Details |
| Gentamicin solution（10mg/mL） | Details |
| Sabourand's Medium | Details |
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (olinvacimab) | Details |
| MIT, 9.5% | Details |
| Ampicillin | C16H19N3O4S | 69-53-4 | Details |
| Anti-vWF Reference Antibody (Ajinomoto patent anti-vWF) | Details |
| NaAc Buffer(3M,pH5.2,RNase-free) | Details |
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (ramucirumab) | Details |
| Tris-HCl Buffer(10mM,pH8.0) | Details |
| Candida Chromogenic Medium | Details |
| Cell Preservation Solution | Details |
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (AT001) | Details |
| Tris-HCl Buffer(1M,pH7.0) | Details |
| Hemicellulose Activity Assay Kit | Details |
| TESCA buffer | Details |
| Anti-vWF Reference Antibody (INSERM patent anti-vWF) | Details |
| SPG buffer(10×,pH4.0) | Details |
| Citric acid trisodium salt | C6H5Na3O7 | Details |
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (vulinacimab) | Details |
| CAPS Buffer(0.5M,pH11.0) | Details |
| 2,2,2-Tribromoethanol | C2H3Br3O | 75-80-9 | Details |
| Anti-VEGFR2 / KDR / CD309 Reference Antibody (Imclone 6.64) | Details |
| Anti-FLAG（DYKDDDDK）Affinity Agarose | Details |
| Colcemid Solution(10μg/mL) | Details |
| Potassium chloride | ClK | 7447-40-7 | Details |
| DMEM Medium Powder(w/o Glucose,Sodium Pyruvate,w/o HEPES,w/o L-Glutamine,w/o Phenol Red) | Details |
| SPG buffer(10×,pH9.0) | Details |
| Tyrode's Solution(HEPES Buffered) | Details |
| Product Total： Product Page： | ||||
| 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 | ||||